Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07290491 · ClinicalTrials.gov registry record · Phase 3
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
A Phase 3 study of Cancer, sponsored by The Methodist Hospital Research Institute.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 854
- Enrollment target
- 1
- Study location
NCT07290491 is a Phase 3 study of Cancer that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 854 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07290491, a Phase 3 study of Cancer, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 854 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase III clinical trial will evaluate the impact on survival of adding chaplain-provided spiritual care or psychotherapy/meditation to standard-of-care (SOC) and palliative measures, plus chemotherapy if recommended, and comparing it with SOC and palliative measures, plus chemotherapy if recommended, in patients with non-curative malignancies. The Palliative Care Department at Houston Methodist Hospital provides essential services to patients diagnosed with advanced cancer by sharing information and resources about symptom management, pain treatment and planning for the future. It is also recognized that chaplaincy-based spiritual care of patients can be a valuable part of interdisciplinary interventions in oncology.
Conditions Studied
Interventions
- BEHAVIORAL Chaplain-Provided Spiritual Care
- BEHAVIORAL Psychotherapy and Meditation Intervention
Study Locations (1)
Texas
- Houston Methodist Neal Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 854 participants |
| Start Date | 2024-06-19 |
| Est. Completion | 2030-05-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07290491
The ClinicalTrials.gov registry entry for NCT07290491 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 854 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (76% lower). The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Chaplain-Provided Spiritual Care is the first listed.
NCT07290491 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07290491 about?
NCT07290491 is a clinical study titled "Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies". This phase III clinical trial will evaluate the impact on survival of adding chaplain-provided spiritual care or psychotherapy/meditation to standard-of-care (SOC) and palliative measures, plus chemotherapy if recommended, and comparing it with SOC and palliative measures, plus chemotherapy if recom...
What is the current status of trial NCT07290491?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 854 participants. The study started on 2024-06-19. Estimated completion is 2030-05-10.
What conditions does trial NCT07290491 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT07290491?
The interventions under investigation include: Chaplain-Provided Spiritual Care (BEHAVIORAL), Psychotherapy and Meditation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07290491?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07290491 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DOAC - Dosing Options in AntiCoagulation Prophylaxis
RECRUITING · Phase 3
-
Abatacept in Immune Checkpoint Inhibitor Myocarditis
RECRUITING · Phase 3
-
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
RECRUITING · Phase 3
-
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
RECRUITING · Phase 3
-
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
RECRUITING · Phase 3
-
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.